Article ; Online: Randomized Trial of Effect of Bariatric Surgery on Blood Pressure After 5 Years.
Journal of the American College of Cardiology
2023 Volume 83, Issue 6, Page(s) 637–648
Abstract: Background: Obesity represents a major obstacle for controlling hypertension, the leading risk factor for cardiovascular mortality.: Objectives: The purpose of this study was to determine the long-term effects of bariatric surgery on hypertension ... ...
Abstract | Background: Obesity represents a major obstacle for controlling hypertension, the leading risk factor for cardiovascular mortality. Objectives: The purpose of this study was to determine the long-term effects of bariatric surgery on hypertension control and remission. Methods: We conducted a randomized clinical trial with subjects with obesity grade 1 or 2 plus hypertension using at least 2 medications. We excluded subjects with previous cardiovascular events and poorly controlled type 2 diabetes. Subjects were assigned to Roux-en-Y gastric bypass (RYGB) combined with medical therapy (MT) or MT alone. We reassessed the original primary outcome (reduction of at least 30% of the total antihypertensive medications while maintaining blood pressure levels <140/90 mm Hg) at 5 years. The main analysis followed the intention-to-treat principle. Results: A total of 100 subjects were included (76% women, age 43.8 ± 9.2 years, body mass index: 36.9 ± 2.7 kg/m Conclusions: Bariatric surgery represents an effective and durable strategy to control hypertension and related polypharmacy in subjects with obesity. (GAstric bypass to Treat obEse Patients With steAdy hYpertension [GATEWAY]; NCT01784848). |
---|---|
MeSH term(s) | Humans ; Female ; Adult ; Middle Aged ; Male ; Blood Pressure ; Antihypertensive Agents/therapeutic use ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/surgery ; Diabetes Mellitus, Type 2/drug therapy ; Bariatric Surgery ; Obesity/complications ; Obesity/surgery ; Gastric Bypass/adverse effects ; Gastric Bypass/methods ; Hypertension/drug therapy ; Hypertension/epidemiology ; Risk Factors ; Treatment Outcome ; Obesity, Morbid/surgery |
Chemical Substances | Antihypertensive Agents |
Language | English |
Publishing date | 2023-12-28 |
Publishing country | United States |
Document type | Randomized Controlled Trial ; Journal Article |
ZDB-ID | 605507-2 |
ISSN | 1558-3597 ; 0735-1097 |
ISSN (online) | 1558-3597 |
ISSN | 0735-1097 |
DOI | 10.1016/j.jacc.2023.11.032 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1846: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 196: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.